Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia
Journal of Infection and Public Health · 2025-09 · 18 (9) · 102836
DOI: 10.1016/j.jiph.2025.102836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2025-09. Verfasst von Yi-Tsung Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care M…. Hauptthemen laut MEDLINE: Ceftazidime, Klebsiella Infections, Bacteremia, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taipei Veterans General Hospital, Ministry of Science and Technology, Taiwan, National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Ele…
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Sch…
- Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Förderung
- Taipei Veterans General Hospital
- Ministry of Science and Technology, Taiwan
- National Science and Technology Council
Zitieren
APA
Lin, Y. T., Lin, S. N., Chuang, C., Liu, S. Y., Ho, Y. C., Juan, C. H., Ho, H. L., & Chou, S. H. (2025). Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia. Journal of Infection and Public Health, 18(9), 102836. https://doi.org/10.1016/j.jiph.2025.102836
Vancouver
Lin YT, Lin SN, Chuang C, Liu SY, Ho YC, Juan CH, et al. Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia. Journal of Infection and Public Health. 2025;18(9):102836. doi:10.1016/j.jiph.2025.102836
BibTeX
@article{Lin2025,
author = {Lin, Yi-Tsung and Lin, Shih-Neng and Chuang, Chien and Liu, Szu-Yu and Ho, Yu-Chien and Juan, Chih-Han and Ho, Hsiang-Ling and Chou, Sheng-Hua},
title = {Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia},
journal = {Journal of Infection and Public Health},
year = {2025},
volume = {18},
number = {9},
pages = {102836},
doi = {10.1016/j.jiph.2025.102836}
}
EUVIMED